294 related articles for article (PubMed ID: 37786592)
61. Strategies to Address Current Challenges in Real-World Evidence Generation in Japan.
Laurent T; Lambrelli D; Wakabayashi R; Hirano T; Kuwatsuru R
Drugs Real World Outcomes; 2023 Jun; 10(2):167-176. PubMed ID: 37178273
[TBL] [Abstract][Full Text] [Related]
62. Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making.
Solà-Morales O; Sigurðardóttir K; Akehurst R; Murphy LA; Mestre-Ferrandiz J; Cunningham D; de Pouvourville G
Value Health; 2023 Apr; 26(4S):32-42. PubMed ID: 36870678
[TBL] [Abstract][Full Text] [Related]
63. Use of real-world evidence in meta-analyses and cost-effectiveness models.
Bowrin K; Briere JB; Levy P; Toumi M; Millier A
J Med Econ; 2020 Oct; 23(10):1053-1060. PubMed ID: 32657189
[TBL] [Abstract][Full Text] [Related]
64. Using RWE research to extend clinical trials in diabetes: An example with implications for the future.
Seeger JD; Nunes A; Loughlin AM
Diabetes Obes Metab; 2020 Apr; 22 Suppl 3(Suppl 3):35-44. PubMed ID: 32250529
[TBL] [Abstract][Full Text] [Related]
65. Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspective.
Zhu M; Sridhar S; Hollingsworth R; Chit A; Kimball T; Murmello K; Greenberg M; Gurunathan S; Chen J
Contemp Clin Trials; 2020 Jul; 94():105856. PubMed ID: 31669449
[TBL] [Abstract][Full Text] [Related]
66. Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications.
Zou KH; Li JZ; Imperato J; Potkar CN; Sethi N; Edwards J; Ray A
J Multidiscip Healthc; 2020; 13():671-679. PubMed ID: 32801731
[TBL] [Abstract][Full Text] [Related]
67. From real world data to real world evidence to improve outcomes in neuro-ophthalmology.
Colman BD; Zhu Z; Qi Z; van der Walt A
Eye (Lond); 2024 Jun; ():. PubMed ID: 38844583
[TBL] [Abstract][Full Text] [Related]
68. Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model.
Li M; Chen S; Lai Y; Liang Z; Wang J; Shi J; Lin H; Yao D; Hu H; Ung COL
Front Med (Lausanne); 2021; 8():669509. PubMed ID: 34136505
[TBL] [Abstract][Full Text] [Related]
69. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?
van Nassau SCMW; Bol GM; van der Baan FH; Roodhart JML; Vink GR; Punt CJA; May AM; Koopman M; Derksen JWG
Curr Treat Options Oncol; 2024 Apr; 25(4):405-426. PubMed ID: 38367182
[TBL] [Abstract][Full Text] [Related]
70. Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes.
Patorno E; Schneeweiss S; Wang SV
Diabetes Obes Metab; 2020 Apr; 22 Suppl 3(Suppl 3):45-59. PubMed ID: 32250527
[TBL] [Abstract][Full Text] [Related]
71. RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design.
Xia AD; Schaefer CP; Szende A; Jahn E; Hirst MJ
Drugs Real World Outcomes; 2019 Dec; 6(4):193-203. PubMed ID: 31741199
[TBL] [Abstract][Full Text] [Related]
72. How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer.
Saesen R; Kantidakis G; Marinus A; Lacombe D; Huys I
Front Pharmacol; 2022; 13():969778. PubMed ID: 36091761
[No Abstract] [Full Text] [Related]
73. A national evaluation analysis and expert interview study of real-world data sources for research and healthcare decision-making.
Mikl V; Baltic D; Czypionka T; Degelsegger-Márquez A; Forgó N; Gouya-Lechner G; Herzog A; Klimek P; Lumenta DB; Mraz B; Ostermann H; Scharinger R; Stamm T; Strassnig M; Zeitlinger M; Pleiner-Duxneuner J
Sci Rep; 2024 Apr; 14(1):9751. PubMed ID: 38679653
[TBL] [Abstract][Full Text] [Related]
74. [The application of real-world evidence in drug regulatory decision-making].
Wicherski J; Haenisch B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Feb; 67(2):149-154. PubMed ID: 38214723
[TBL] [Abstract][Full Text] [Related]
75. Using Real-World Data in the Health Technology Assessment of Pharmaceuticals: Strengths, Difficulties, and a Pragmatic Way Forward.
Akehurst R; Murphy LA; Solà-Morales O; Cunningham D; Mestre-Ferrandiz J; de Pouvourville G
Value Health; 2023 Apr; 26(4S):11-19. PubMed ID: 36706952
[TBL] [Abstract][Full Text] [Related]
76. Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan.
Maeda H; Ng DB
Front Med (Lausanne); 2022; 9():864960. PubMed ID: 35492312
[TBL] [Abstract][Full Text] [Related]
77. Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization.
Schaumberg D; Larholt K; Apgar E; Pashos CL; Hirsch G
Ther Innov Regul Sci; 2023 May; 57(3):472-475. PubMed ID: 36624361
[TBL] [Abstract][Full Text] [Related]
78. Making Clinical Practice Guidelines Pragmatic: How Big Data and Real World Evidence Can Close the Gap.
Chew SY; Koh MS; Loo CM; Thumboo J; Shantakumar S; Matchar DB
Ann Acad Med Singap; 2018 Dec; 47(12):523-527. PubMed ID: 30636269
[TBL] [Abstract][Full Text] [Related]
79. Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement.
Snyder JM; Pawloski JA; Poisson LM
Curr Oncol Rep; 2020 Apr; 22(5):45. PubMed ID: 32297007
[TBL] [Abstract][Full Text] [Related]
80. Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies.
Hou J; Zhao R; Gronsbell J; Lin Y; Bonzel CL; Zeng Q; Zhang S; Beaulieu-Jones BK; Weber GM; Jemielita T; Wan SS; Hong C; Cai T; Wen J; Ayakulangara Panickan V; Liaw KL; Liao K; Cai T
J Med Internet Res; 2023 May; 25():e45662. PubMed ID: 37227772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
